Evoke Pharma

- NASDAQ:EVOK
Last Updated 2021-07-26
  • Evoke Pharma develops therapeutics for the treatment of gastrointestinal diseases.
  • Locations

    • San Diego CA
  • Total Funding (USD)

    13.8 million
  • Industries

    Real Estate, Mobile Apps, Video Games, Cyber Security
  • Security

    Type: ORD
    CUSIP: 30049G104
    ISIN: US30049G1040
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.